Vertex Pharmaceuticals (VRTX)

Long-Term Debt

$1.98B

Quarterly · Period ending: · USD

VRTX logo

VRTX Long-Term Debt

Latest reported$1.98B
VRTX Quarterly Long-Term Debt ($2.40M → $1.98B)
High-resolution chart · PNG

VRTX long-term debt history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Vertex Pharmaceuticals Long-Term Debt — Quarterly (USD)
Period endingLong-Term Debt (USD)
1,977,600,000
1,986,500,000
3,799,700,000
1,834,800,000
1,527,400,000
1,649,100,000
1,657,200,000
1,702,900,000
933,400,000
721,300,000
724,700,000
744,700,000
767,600,000
789,200,000
810,300,000
824,600,000
847,300,000
872,500,000
887,200,000
876,800,000
893,849,000
898,797,000
889,500,000
546,514,000
522,067,000
532,952,000
622,868,000
604,539,000
611,963,000
623,865,000
581,550,000
576,530,000
577,675,000
578,206,000
583,902,000
567,310,000
550,365,000
529,130,000
521,335,000
504,792,000
581,612,000
660,951,000
739,397,000
806,829,000
767,673,000
785,708,000
792,935,000
810,112,000
518,321,000
522,855,000
489,691,000
431,950,000
387,188,000
731,576,000
683,201,000
400,000,000
-181,539,000
-83,451,000
455,950,000
180,375,000
146,843,000
246,373,000
400,000,000
77,462,000
128,272,000
-403,458,000
-6,136,000
-290,381,000
144,000,000
287,500,000
287,500,000
287,500,000
287,500,000
287,500,000
0
0
0
19,997,000
19,997,000
59,648,000
117,993,000
117,998,000
0
232,448,000
232,448,000
232,448,000
0
232,448,000
153,135,000
0
359,188,000
0
0
328,523,000
325,944,000
321,313,000
321,730,000
322,331,000
323,026,000
354,185,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.